Track topics on Twitter Track topics that are important to you
A $210.5 million convertible loan facility has been reached by Endologix with three unnamed investors. -More-
Endologix Inc., a developer and marketer of innovative treatments for aortic disorders, announced today that it has received notice that the U.S. Food and Drug Administration has classified a voluntar...
Endologix Inc. (minimally invasive devices for aortic disorders) netted $19.8mm through the follow-on public offering of 17.65mm common shares at $1.1329 each. The company will use the funds to redeem...
Endologix Inc. (minimally invasive devices for aortic disorders) announced a $210.5mm convertible loan facility with three undisclosed investors. The company also issued warrants.
A recall been initiated by Endologix involving its AFX Endovascular AAA System, a device designed for abdominal aortic aneury -More-
Endologix is commencing a public offering in hopes of raising $20 million. -More-
Endologix has pushed its timeline for FDA premarket approval of its Nellix 3.5 endovascular sealing system to the first half -More-
Endologix, Inc. (Nasdaq:ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, today announced that it will host a m...
Despite recent publications indicating billowing (aneurysmal degeneration of the outer fabric material manifesting as a bulging sac of contained contrast due to weakening of the fabric material betwee...
The objective of this study is to assess the safety and effectiveness of the Endologix Nellix® System for the endovascular repair of infrarenal abdominal aortic aneurysms (AAA).
Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's flagship product is the Powerlink® System, which is an endovascular stent graft for the tre...
Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's focus is endovascular stent grafts for the treatment of abdominal aorti...
Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology for the treatment of...
We have published hundreds of Endologix, Inc. news stories on BioPortfolio along with dozens of Endologix, Inc. Clinical Trials and PubMed Articles about Endologix, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Endologix, Inc. Companies in our database. You can also find out about relevant Endologix, Inc. Drugs and Medications on this site too.
A stent is a small mesh tube that's used to treat narrow or weak arteries. Arteries are blood vessels that carry blood away from your heart to other parts of your body. A stent is placed in an artery as part of a procedure called angioplasty. &...